Guardant Health to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Guardant Health (Nasdaq: GH), a precision oncology company, has announced its participation in four major upcoming investor conferences. The company will attend the BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT, hosting one-on-one meetings on February 11th-12th.

Additionally, Guardant Health will participate in three March conferences: the TD Cowen 45th Annual Health Care Conference in Boston (March 4th, 10:30 AM ET), the Leerink Partners Global Health Conference in Miami (March 11th, 4:20 PM ET), and the Barclays 27th Annual Global Healthcare Conference in Miami Beach (March 12th, 1:30 PM ET).

Interested investors can access live and archived webcasts of these sessions through the Investors section of Guardant Health's website.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

• BTIG 12^th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT
  Hosting 1x1 meetings on Tuesday, February 11^th and Wednesday, February 12^th

• TD Cowen 45^th Annual Health Care Conference in Boston, MA
  Fireside chat on Tuesday, March 4^th at 10:30 a.m. Eastern Time

• Leerink Partners Global Health Conference in Miami, FL
  Fireside chat on Tuesday, March 11^th at 4:20 p.m. Eastern Time

• Barclays 27^th Annual Global Healthcare Conference in Miami Beach, FL
  Fireside chat on Wednesday, March 12^th at 1:30 p.m. Eastern Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Source: Guardant Health, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250210319626/en/

Investor Contact:

Zarak Khurshid

investors@guardanthealth.com

Media Contact:

Melissa Marasco

press@guardanthealth.com

+1 650-647-3711

Source: Guardant Health, Inc.

FAQ

Which investor conferences will Guardant Health (GH) attend in February 2024?

Guardant Health will attend the BTIG 12th Annual MedTech Conference in Snowbird, UT, hosting 1x1 meetings on February 11th and 12th.

What time is Guardant Health's (GH) presentation at the TD Cowen Healthcare Conference?

Guardant Health will present at the TD Cowen Healthcare Conference on March 4th at 10:30 AM Eastern Time.

How can investors access Guardant Health's (GH) conference presentations?

Investors can access live and archived webcasts of the sessions through the 'Investors' section of Guardant Health's website at www.guardanthealth.com.

What are the dates and times for Guardant Health's (GH) March 2024 conference presentations?

Guardant Health will present at TD Cowen on March 4th at 10:30 AM ET, Leerink Partners on March 11th at 4:20 PM ET, and Barclays on March 12th at 1:30 PM ET.